Delivra Health Brands Future Growth
Future criteria checks 1/6
Delivra Health Brands is forecast to grow earnings and revenue by 157% and 13.2% per annum respectively while EPS is expected to grow by 158.1% per annum.
Key information
157.0%
Earnings growth rate
158.1%
EPS growth rate
Pharmaceuticals earnings growth | 56.7% |
Revenue growth rate | 13.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 01 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 14 | 0 | N/A | 1 | 1 |
6/30/2024 | 12 | 0 | 1 | 1 | 1 |
12/31/2023 | 11 | -1 | -1 | -1 | N/A |
9/30/2023 | 12 | 0 | -1 | -1 | N/A |
6/30/2023 | 10 | 0 | -1 | -1 | N/A |
3/31/2023 | 8 | -2 | -2 | -2 | N/A |
12/31/2022 | 8 | -3 | -2 | -2 | N/A |
9/30/2022 | 8 | -6 | -3 | -3 | N/A |
6/30/2022 | 8 | -7 | -4 | -4 | N/A |
3/31/2022 | 8 | -12 | -5 | -5 | N/A |
12/31/2021 | 8 | -12 | -5 | -5 | N/A |
9/30/2021 | 8 | -21 | -7 | -7 | N/A |
6/30/2021 | 8 | -23 | -10 | -10 | N/A |
3/31/2021 | 8 | -24 | -10 | -8 | N/A |
12/31/2020 | 8 | -54 | -13 | -11 | N/A |
9/30/2020 | 8 | -55 | -15 | -11 | N/A |
6/30/2020 | 8 | -57 | -25 | -18 | N/A |
3/31/2020 | 3 | -60 | -33 | -25 | N/A |
12/31/2019 | 4 | -34 | -37 | -25 | N/A |
9/30/2019 | 6 | -26 | -37 | -24 | N/A |
6/30/2019 | 6 | -26 | -31 | -20 | N/A |
3/31/2019 | 9 | -19 | -27 | -19 | N/A |
12/31/2018 | 6 | -17 | -22 | -16 | N/A |
9/30/2018 | 2 | -17 | -18 | -16 | N/A |
6/30/2018 | 1 | -13 | -14 | -11 | N/A |
3/31/2018 | 0 | -13 | -12 | -7 | N/A |
12/31/2017 | 0 | -12 | -11 | -7 | N/A |
9/30/2017 | 0 | -10 | N/A | -5 | N/A |
6/30/2017 | 0 | -8 | N/A | -4 | N/A |
3/31/2017 | 0 | -4 | N/A | -3 | N/A |
12/31/2016 | 0 | -3 | N/A | -3 | N/A |
9/30/2016 | 0 | -3 | N/A | -3 | N/A |
6/30/2016 | 0 | -3 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DHB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DHB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DHB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DHB's revenue (13.2% per year) is forecast to grow faster than the Canadian market (6.7% per year).
High Growth Revenue: DHB's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DHB's Return on Equity is forecast to be high in 3 years time